You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

afatinib

Showing 1 - 25 of 96
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Stomach Tumor Trial (Trastuzumab deruxtecan, Afatinib)

Not yet recruiting
  • Stomach Neoplasm
  • Trastuzumab deruxtecan
  • Afatinib
  • (no location specified)
Oct 16, 2023

Gastric Cancer, Gastroesophageal Junction Cancer Trial in Seoul (afatinib, paclitaxel)

Completed
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System, Yonsei Canc
Jan 26, 2023

Esophagus Squamous Cell Carcinoma Trial in Beijing (Palbociclib, Afatinib)

Recruiting
  • Esophagus Squamous Cell Carcinoma
  • Beijing, Beijing, China
    National Cancer Center/Cancer Hospital, Chinese Academy of Medic
May 17, 2023

Real-world Data of Afatinib Treatment in First-line Setting and

Active, not recruiting
  • Non-squamous, Non-Small Cell Lung Cancer
  • afatinib
  • Tokyo, Japan
    Nippon Boehringer Ingelheim Co., Ltd.
Jan 9, 2023

Advanced Esophageal Squamous Cell Carcinoma Trial in Beijing, Xiamen, Xinxiang (Afatinib, Irinotecan)

Recruiting
  • Advanced Esophageal Squamous Cell Carcinoma
  • Beijing, China
  • +2 more
Apr 6, 2023

Solid Tumors Trial (afatinib)

No longer available
  • Solid Tumors
  • afatinib
  • (no location specified)
Nov 7, 2022

Squamous Cell Cancers of the Head and Neck Trial in New Haven (cetuximab, afatinib)

Recruiting
  • Squamous Cell Cancers of the Head and Neck
  • New Haven, Connecticut
    Yale Cancer Center
Jan 10, 2023

Head and Neck Squamous Cell Carcinoma Trial (Nab-paclitaxel, Cisplatin, Tislelizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Aug 23, 2022

NSCLC Trial in Worldwide (Afatinib)

Completed
Has Results
  • NSCLC
  • Afatinib
  • Köln, Germany
  • +4 more
Aug 23, 2022

Observational Study of Afatinib 30 mg Daily

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Epidermal Growth Factor Receptor Mutation
  • Afatinib
  • Singapore, Singapore
    Nationa University Hospital
Apr 4, 2022

Observes Afatinib as First-line Treatment and Sequential Therapy

Active, not recruiting
  • Non-squamous, Non-Small Cell Lung Cancer
  • Afatinib
  • Beijing, China
  • +9 more
Jan 9, 2023

Brain Cancer Trial in Santa Monica (Afatinib)

Completed
  • Brain Cancer
  • Afatinib
  • Santa Monica, California
    John Wayne Cancer Institute
Mar 8, 2022

Lung Adenocarcinoma Stage III, EGFR Gene Mutation Trial in Shang'ai (Afatinib)

Recruiting
  • Lung Adenocarcinoma Stage III
  • EGFR Gene Mutation
  • Afatinib
  • Shang'ai, Shanghai, China
    Shanghai Pulmonary Hospital
Mar 27, 2022

Solid Tumors Trial in Toronto (Afatinib)

Active, not recruiting
  • Solid Tumors
  • Afatinib
  • Toronto, Ontario, Canada
    Princess Margaret Cancer Centre
May 12, 2022

Non-Small Cell Lung Carcinoma Trial in Duarte, Stanford, Nashville (drug, biological, other)

Terminated
  • Non-Small Cell Lung Carcinoma
  • Afatinib
  • +2 more
  • Duarte, California
  • +2 more
Apr 6, 2022

PFS Trial in Qingdao (afatinib)

Recruiting
  • PFS
  • afatinib
  • Qingdao, Shandong, China
  • +1 more
Feb 23, 2022

Afatinib Following Immunotherapy in Treatment of Metastatic,

Completed
  • Non-squamous, Non-Small Cell Lung Cancer
  • Afatinib
  • other systemic therapy
  • Dublin, Ohio
    Cardinal Health
Jan 18, 2022

NSCLC Trial in United Kingdom (Afatinib)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • Afatinib
  • Aberdeen, United Kingdom
  • +6 more
Feb 22, 2022

Esophageal Squamous Carcinoma Trial in China (JMT101, Afatinib)

Recruiting
  • Esophageal Squamous Carcinoma
  • Beijing, Beijing, China
  • +4 more
Dec 18, 2021

Non Small Cell Lung Cancer Trial in France (Afatinib, Cetuximab)

Completed
  • Non Small Cell Lung Cancer
  • Aix-en-Provence, France
  • +32 more
Aug 9, 2022

NSCLC Trial in Amsterdam, Groningen, Maastricht (Afatinib, Cetuximab)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Amsterdam, North-Holland, Netherlands
  • +3 more
Oct 19, 2021

Lung Tumors, EGFR Gene Mutation Trial in Hwasun (Afatinib)

Completed
  • Lung Neoplasms
  • EGFR Gene Mutation
  • Afatinib
  • Hwasun, Jeonnam, Korea, Republic of
    Chonnam National University Hwasun Hospital
Aug 1, 2021

Esophageal Squamous Cell Carcinoma Trial in Beijing (Afatinib, Toripalimab)

Not yet recruiting
  • Esophageal Squamous Cell Carcinoma
  • Beijing, Beijing, China
    Peking University Cancer Hospital and Institute
Jul 11, 2021

Cancer Medicines in Metastatic Non-small Cell Lung Cancer in

Not yet recruiting
  • Non-Small Cell Lung Cancer
  • Oslo, Norway
    Pfizer Norway
Apr 17, 2023

Glioblastoma, Recurrent Disease, Recurrent Glioblastoma Trial in Calgary (Afatinib, Dasatinib, Palbociclib)

Not yet recruiting
  • Glioblastoma
  • +2 more
  • Afatinib
  • +4 more
  • Calgary, Alberta, Canada
    Tom Baker Cancer Centre
Jun 24, 2022